A free two-day event in Cambridge will unite experts to discuss translational advances in cell and gene therapy, spanning rare diseases, cancer immunotherapy, and genome editing.

An exclusive development deal integrates affinity based cell isolation into an automated system that rapidly extracts T cells from blood or apheresis. The approach aims to boost manufacturing ...

Following renewed concern over Nipah virus infections in India, Sino Biological announced rapid availability of recombinant ...

Researchers at Nuclera completed the first Asian installations of its eProtein Discovery System at National Taiwan University ...

OutSee closed a £2.5M seed round and partnered with o2h discovery to launch a drug discovery program using its AI-powered ...

Using a structured matchmaking framework, the pilot connects university labs with industry research teams through targeted ...

PATINA Phase 3 study found that adding palbociclib to standard therapy for HR+, HER2+ breast cancer extends median ...

PacBio launched CiFi, a method combining 3C and HiFi long-read sequencing to generate chromosome scale, haplotype resolved ...

Nuclera extended its Series C with $12M, bringing total to $87M, to expand Protein Discovery with full-format antibody ...

Data from COVID-19 lockdowns show atmospheric TFA levels fell quickly with reduced activity, suggesting this persistent PFAS ...

A study shows airborne mineral dust delivers nutrients like phosphorus to Greenland’s ice, fueling glacier algae growth.

Using defined media and extracellular matrices, researchers show that hiPSC pre-culture conditions strongly influence ...